Introduction Percutaneous pulmonary valve implantation is now considered feasible and
safe.“Native” right ventricular outflow tract (RVOT), small diameter conduits (< 16 mm) and …

Background Although widely accepted worldwide, indications for percutaneous valve
replacement are limited to treatment of dysfunction of prosthetic conduits inserted in the right …

Aims Percutaneous pulmonary valve implantation (PPVI) is now an accepted treatment
strategy for right ventricular (RV) outflow tract (RVOT) dysfunction in many European Heart …

Objective The aim of this study was to determine early and long-term results after
transcatheter pulmonary valve implantation (TPVI) performed with the use of Medtronic …

Objectives This article sought to describe a new modification of the Melody valve that allows
percutaneous pulmonary valve implantation (PPVI) in complex outflow tracts. Background …

Background Percutaneous pulmonary valve implantation (PPVI) was introduced in 2000 as
an interventional procedure for the treatment of right ventricular outflow tract (RVOT) …

Percutaneous pulmonary valve implantation now has a key role in the setting of
dysfunctional right ventricle-to-pulmonary artery conduits or failing bioprosthetic pulmonary …

Objectives: This study sought to review the outcomes for the Sapien and Sapien XT valves
(Edwards Lifesciences, Irvine, California) for percutaneous pulmonary valve implantation …

OBJECTIVES Since percutaneous pulmonary valve implantation (PPVI) was introduced to
prolong the lifetime of surgically placed right ventricular to pulmonary artery conduits, valve …

Background: To investigate the feasibility and mid-term results of percutaneous pulmonary
valve implantation (PPVI) in patients with conduit free or “native” right ventricular outflow …